Libman-Sacks endocarditis and severe aortic regurgitation in a patient with systemic lupus erythematosus in peritoneal dialysis;Endocarditis de Libman-Sacks e insuficiencia aórtica grave en un paciente con lupus eritematoso sistémico en diálisis peritoneal

Nefrologia

Volumn 31, Issue 5, 2011, Pages 619-621

  Delgado, Y Barreiro ^a   Méndez, I García ^a   Alemany, N Martín ^a   Martínez, J Calabia ^a   Fornos, M Morales ^a   Fuertes, M ^a   Rats, M Vallès ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT;

AORTA VALVE REGURGITATION; CASE REPORT; DRUG COMBINATION; ENDOCARDITIS; FEMALE; HEART VALVE REPLACEMENT; HUMAN; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PERICARDIAL EFFUSION; PERITONEAL DIALYSIS; PERITONITIS; RENAL REPLACEMENT THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTI-BACTERIAL AGENTS; AORTIC VALVE INSUFFICIENCY; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; ENDOCARDITIS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MIDDLE AGED; PERICARDIAL EFFUSION; PERITONEAL DIALYSIS; PERITONITIS; RENAL DIALYSIS;

EID: 83755184060     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Jun.10939     Document Type: Letter

References (8)

1. Bouma W, Klinkengerg TJ, Van der Horst ICC, Wijdh-den Hamer IJ, Erasmus ME, Bijl M, et al. Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systemic review of literature. J Cardiothor Surg 2010;5:1-13.
2. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematus valve disease by transesophageal echocardiography and role of antifosfolipidid antibodies. J Am Coll Cardiol 1992;20:1127-34.
3. Moyssakis I, Tektonidou MG, Vasillous A, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 2007;120:636-42.
4. Grzegorzewska AE, Leander M. Lymphocyte subsets in the course of continuos ambulatory peritoneal dialysis. Perit Dial 2001;17:10-4.
5. Young Suck Goo, Hyeon Cheon Park, Hooon Young Choi. The evolution of lupus activity among patients with endstage renal disease secondary to lupus nephritis. Yonsei Med J 2004;45(2):199-206.
6. Chih-Chia Liang, Chiu-Ching Huang, I-Kuan Wang, Chiz-Tzung, Kuan-Hsing Chen, Cheng-Hao Weng, et al. Impact of renal survival on the course and outcome of systemic lupus erythemayosus patients treated with chronic peritoneal dialysis. Ther Apher Dial 2009;14:35-42.
7. Yui Pong Siu, Kay Tai Leung, Matthew Ka Hang Tong, Tze Hoi Kwan, Chi Chiu Mok. Clinical outcomes of systemic lupus erythematosus patients undergoing continous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2005;20:2797-802.
8. Szeto CC, Li PK. Reactivation of systemic lupus erythematosus after end-stage renal disease. J Rheumatol 1998;25:1520-5.